|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 614-621, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DE Low, LR Kaiser, DA Haydock, E Trulock and JD Cooper
The prevalence of posttransplantation pulmonary infection and the
importance of this complication with respect to morbidity in patients
undergoing lung transplantation is significant. Over a 1-year period, case
histories of all patients undergoing lung transplantation at Barnes
Hospital, Washington University, were reviewed to examine the importance of
organisms isolated in the donor lung in the development of subsequent
invasive infection in transplant recipients. Twenty-eight of 29 bronchial
washings (97%) taken from donors before retrieval grew at least one
organism. The most common organisms identified were Staphylococcus and
Enterobacter. In 12 of these cases (43%), similar organisms were isolated
from the tracheobronchial tree of the recipients, and 6 of these recipients
(21%) subsequently had invasive pulmonary infections as a result of the
organism originally isolated in the donor. We recommend that antibiotic
coverage in transplant recipients should be initiated on the basis of Gram
stain results and modified on the basis of cultures obtained from the donor
lungs. Pathologic analysis of donor lung tissue taken before
transplantation was available in 12 cases. Four donors had histologic
evidence of established pneumonia in the donor lung, and infections then
developed in the recipients. One other patient who received a lung that had
widespread bone marrow emboli and subsequent infarction later had a
complete anastomotic dehiscence. An additional patient had profound early
donor lung dysfunction without any evidence of rejection or infection.
Pathologic findings from the donor in this case demonstrated preexistent
acute vasculitis with emboli. We suggest that as preservation techniques
improve, the opportunities for closer scrutiny of donor lung tissue before
implantation will become increasing desirable and feasible.
ARTICLES
The donor lung: infectious and pathologic factors affecting outcome in lung transplantation
Department of Cardiothoracic Surgery, Barnes Hospital, Washington University, St. Louis, MO.
This article has been cited by other articles:
![]() |
D. Lardinois, M. Banysch, S. Korom, S. Hillinger, V. Rousson, A. Boehler, R. Speich, and W. Weder Extended donor lungs: eleven years experience in a consecutive series Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 762 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Avlonitis, A. Krause, L. Luzzi, H. Powell, J. A. Phillips, P. A. Corris, F. K. Gould, and J. H. Dark Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Gotway, S. K. Dawn, D. Sellami, J. A. Golden, G. P. Reddy, F. M. Keith, and W. R. Webb Acute Rejection Following Lung Transplantation: Limitations in Accuracy of Thin-Section CT for Diagnosis Radiology, October 1, 2001; 221(1): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Dowling, P. Williams, M. Zenati, B. P. Griffith, and R. L. Hardesty Infections and pathologic factors in the donor lung J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1263 - 1264. [Full Text] |
||||
![]() |
K. Bando, I. L. Paradis, K. Komatsu, H. Konishi, M. Matsushima, R. J. Keenan, R. L. Hardesty, J. M. Armitage, and B. P. Griffith Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 49 - 59. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |